vs

Side-by-side financial comparison of ARDELYX, INC. (ARDX) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

ARDELYX, INC. is the larger business by last-quarter revenue ($125.2M vs $66.7M, roughly 1.9× RMR GROUP INC.). On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs 7.8%).

Ardelyx, Inc. is a commercial-stage biopharmaceutical firm developing and commercializing innovative therapies for gastrointestinal, cardiorenal and metabolic diseases with high unmet medical needs. Its lead product is approved in the US for irritable bowel syndrome with constipation, and it holds a robust pipeline of early and late-stage drug candidates.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

ARDX vs RMR — Head-to-Head

Bigger by revenue
ARDX
ARDX
1.9× larger
ARDX
$125.2M
$66.7M
RMR
Growing faster (revenue YoY)
RMR
RMR
+32.9% gap
RMR
40.8%
7.8%
ARDX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ARDX
ARDX
RMR
RMR
Revenue
$125.2M
$66.7M
Net Profit
$12.2M
Gross Margin
Operating Margin
48.1%
Net Margin
18.3%
Revenue YoY
7.8%
40.8%
Net Profit YoY
91.1%
EPS (diluted)
$0.00
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARDX
ARDX
RMR
RMR
Q1 26
$125.2M
Q4 25
$125.2M
$66.7M
Q3 25
$110.3M
Q2 25
$97.7M
Q1 25
$74.1M
Q4 24
$116.1M
Q3 24
$98.2M
Q2 24
$73.2M
Net Profit
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
$-407.0K
$12.2M
Q3 25
$-969.0K
Q2 25
$-19.1M
Q1 25
$-41.1M
Q4 24
$4.6M
Q3 24
$-809.0K
Q2 24
$-16.5M
Gross Margin
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
91.3%
Q3 25
96.4%
Q2 25
87.3%
Q1 25
83.4%
Q4 24
84.3%
Q3 24
84.0%
Q2 24
87.1%
Operating Margin
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
4.1%
48.1%
Q3 25
4.2%
Q2 25
-14.7%
Q1 25
-49.0%
Q4 24
7.0%
Q3 24
2.3%
Q2 24
-18.6%
Net Margin
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
-0.3%
18.3%
Q3 25
-0.9%
Q2 25
-19.5%
Q1 25
-55.5%
Q4 24
4.0%
Q3 24
-0.8%
Q2 24
-22.5%
EPS (diluted)
ARDX
ARDX
RMR
RMR
Q1 26
$0.00
Q4 25
$-0.01
$0.71
Q3 25
$0.00
Q2 25
$-0.08
Q1 25
$-0.17
Q4 24
$0.01
Q3 24
$0.00
Q2 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARDX
ARDX
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$264.7M
$49.3M
Total DebtLower is stronger
$202.8M
Stockholders' EquityBook value
$166.9M
$232.7M
Total Assets
$501.6M
$687.1M
Debt / EquityLower = less leverage
1.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARDX
ARDX
RMR
RMR
Q1 26
$264.7M
Q4 25
$68.0M
$49.3M
Q3 25
$42.7M
Q2 25
$90.0M
Q1 25
$30.8M
Q4 24
$64.9M
Q3 24
$47.4M
Q2 24
$41.9M
Total Debt
ARDX
ARDX
RMR
RMR
Q1 26
$202.8M
Q4 25
$202.8M
Q3 25
$202.1M
Q2 25
$201.4M
Q1 25
$151.3M
Q4 24
$150.9M
Q3 24
$100.7M
Q2 24
$100.2M
Stockholders' Equity
ARDX
ARDX
RMR
RMR
Q1 26
$166.9M
Q4 25
$166.9M
$232.7M
Q3 25
$154.3M
Q2 25
$139.5M
Q1 25
$145.7M
Q4 24
$173.3M
Q3 24
$158.3M
Q2 24
$147.0M
Total Assets
ARDX
ARDX
RMR
RMR
Q1 26
$501.6M
Q4 25
$501.6M
$687.1M
Q3 25
$486.2M
Q2 25
$466.8M
Q1 25
$410.2M
Q4 24
$435.8M
Q3 24
$367.9M
Q2 24
$343.5M
Debt / Equity
ARDX
ARDX
RMR
RMR
Q1 26
1.21×
Q4 25
1.21×
Q3 25
1.31×
Q2 25
1.44×
Q1 25
1.04×
Q4 24
0.87×
Q3 24
0.64×
Q2 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARDX
ARDX
RMR
RMR
Operating Cash FlowLast quarter
$10.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
$21.0M
$10.7M
Q3 25
$365.0K
Q2 25
$-25.3M
Q1 25
$-38.5M
Q4 24
$9.8M
Q3 24
$501.0K
Q2 24
$-19.4M
Free Cash Flow
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
$20.6M
Q3 25
$209.0K
Q2 25
$-26.0M
Q1 25
$-38.8M
Q4 24
$9.2M
Q3 24
$364.0K
Q2 24
$-19.5M
FCF Margin
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
16.4%
Q3 25
0.2%
Q2 25
-26.6%
Q1 25
-52.3%
Q4 24
7.9%
Q3 24
0.4%
Q2 24
-26.7%
Capex Intensity
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
0.3%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.2%
Cash Conversion
ARDX
ARDX
RMR
RMR
Q1 26
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
2.11×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARDX
ARDX

IBSRELA$86.6M69%
XPHOZAH$27.8M22%
Product supply revenue$9.4M8%
Non-cash royalty revenue related to the sale of future royalties$1.4M1%
Licensing revenue$23.0K0%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons